Journal of the American Heart Association

TORONTO, Ontario, July 14, 2026 Cardiol Therapeutics Inc. has announced the publication of its Phase II MAvERIC clinical trial...

TORONTO, ON, May 7, 2026 Cardiol Therapeutics Inc. announced that results from its Phase II MAvERIC study evaluating CardiolRx™...